CVS HEALTH Corp (CVS)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

2Y 5Y 10Y All
Quarterly Annual TTM

Revenue TTM

0 150B 300B 450B Q3 '21: 285.1B Q4 '21: 292.1B Q1 '22: 299.8B Q2 '22: 307.9B Q3 '22: 315.2B Q4 '22: 322.5B Q1 '23: 330.9B Q2 '23: 339.2B Q3 '23: 347.8B Q4 '23: 357.8B Q1 '24: 360.9B Q2 '24: 363.2B Q3 '24: 368.9B Q4 '24: 372.8B Q1 '25: 379B Q2 '25: 386.6B Q3 '25: 394.1B Q4 '25: 402.1B Q1 '26: 407.9B Q2 '26: 415.1B Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Gross Profit TTM

0 10B 20B 30B Q4 '13: 23.8B Q1 '14: 24.1B Q2 '14: 24.6B Q3 '14: 25.1B Q4 '14: 25.4B Q1 '15: 25.6B Q2 '15: 25.7B Q3 '15: 25.9B Q4 '15: 26.5B Q1 '16: 27.1B Q2 '16: 27.7B Q3 '16: 28.6B Q4 '16: 28.9B Q1 '17: 28.7B Q2 '17: 28.6B Q3 '17: 28.2B Q4 '17: 28.5B Q1 '18: 28.8B Q2 '18: 29.1B Q3 '18: 29.3B Q1 '14 Q4 '14 Q3 '15 Q2 '16 Q1 '17 Q4 '17 Q3 '18

Operating Income TTM

0 5B 10B 15B Q3 '21: 13.5B Q4 '21: 13.3B Q1 '22: 13.3B Q2 '22: 13.6B Q3 '22: 6.6B Q4 '22: 8B Q1 '23: 7.9B Q2 '23: 6.4B Q3 '23: 14B Q4 '23: 13.7B Q1 '24: 12.6B Q2 '24: 12.4B Q3 '24: 9.5B Q4 '24: 8.5B Q1 '25: 9.6B Q2 '25: 9B Q3 '25: 4.9B Q4 '25: 4.7B Q1 '26: 6B Q2 '26: 8.3B Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Net Income TTM

0 3B 6B 9B Q3 '21: 7.6B Q4 '21: 8B Q1 '22: 8.1B Q2 '22: 8.4B Q3 '22: 3.4B Q4 '22: 4.3B Q1 '23: 4.1B Q2 '23: 3B Q3 '23: 8.6B Q4 '23: 8.3B Q1 '24: 7.3B Q2 '24: 7.2B Q3 '24: 5B Q4 '24: 4.6B Q1 '25: 5.3B Q2 '25: 4.5B Q3 '25: 469M Q4 '25: 1.8B Q1 '26: 2.9B Q2 '26: 4.9B Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Cost of Revenue TTM

0 80B 160B 240B Q3 '21: 171.9B Q4 '21: 175.8B Q1 '22: 180.4B Q2 '22: 186.2B Q3 '22: 191.5B Q4 '22: 196.9B Q1 '23: 202.8B Q2 '23: 207.1B Q3 '23: 211.4B Q4 '23: 217.1B Q1 '24: 213.7B Q2 '24: 210.2B Q3 '24: 208.4B Q4 '24: 206.3B Q1 '25: 209.3B Q2 '25: 213.3B Q3 '25: 217.4B Q4 '25: 221.2B Q1 '26: 225.6B Q2 '26: 230.4B Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Operating Cash Flow TTM

0 8B 16B 24B Q3 '19: 12.7B Q4 '19: 12.8B Q1 '20: 14.2B Q2 '20: 16B Q3 '20: 14.9B Q4 '20: 15.9B Q1 '21: 15.5B Q2 '21: 14.2B Q3 '21: 17.8B Q4 '21: 18.3B Q1 '22: 18.9B Q2 '22: 18.5B Q3 '22: 22.1B Q4 '24: 9.1B Q1 '25: 8.8B Q2 '25: 7.6B Q3 '25: 9.1B Q4 '25: 10.6B Q1 '26: 10.3B Q2 '26: 14.8B Q4 '19 Q3 '20 Q2 '21 Q1 '22 Q4 '24 Q3 '25 Q2 '26

Free Cash Flow TTM

0 7B 14B 21B Q3 '19: 10.2B Q4 '19: 10.4B Q1 '20: 11.7B Q2 '20: 13.6B Q3 '20: 12.6B Q4 '20: 13.4B Q1 '21: 12.9B Q2 '21: 11.6B Q3 '21: 15.2B Q4 '21: 15.7B Q1 '22: 16.2B Q2 '22: 15.9B Q3 '22: 19.5B Q4 '24: 6.3B Q1 '25: 5.9B Q2 '25: 4.8B Q3 '25: 6.3B Q4 '25: 7.8B Q1 '26: 7.4B Q2 '26: 11.8B Q4 '19 Q3 '20 Q2 '21 Q1 '22 Q4 '24 Q3 '25 Q2 '26

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 500M 1B 1.5B Q1 '20: 1.3B Q2 '20: 1.3B Q3 '20: 1.3B Q1 '21: 1.3B Q2 '21: 1.3B Q3 '21: 1.3B Q1 '22: 1.3B Q2 '22: 1.3B Q3 '22: 1.3B Q1 '23: 1.3B Q2 '23: 1.3B Q3 '23: 1.3B Q1 '24: 1.3B Q2 '24: 1.3B Q3 '24: 1.3B Q1 '25: 1.3B Q2 '25: 1.3B Q3 '25: 1.3B Q1 '26: 1.3B Q2 '26: 1.3B Q2 '20 Q2 '21 Q2 '22 Q2 '23 Q2 '24 Q2 '25 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

0.00 2.50 5.00 7.50 Q3 '21: 5.72 Q4 '21: 6.02 Q1 '22: 6.11 Q2 '22: 6.30 Q3 '22: 2.51 Q4 '22: 3.26 Q1 '23: 3.14 Q2 '23: 2.33 Q3 '23: 6.67 Q4 '23: 6.47 Q1 '24: 5.70 Q2 '24: 5.63 Q3 '24: 3.95 Q4 '24: 3.67 Q1 '25: 4.20 Q2 '25: 3.59 Q3 '25: 0.39 Q4 '25: 1.39 Q1 '26: 2.28 Q2 '26: 3.79 Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.